| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019579A1 Nuclear protein serine/threonine kinases |
| 06/27/1996 | WO1996019567A1 Method for gene transfer into cells activated out of a quiescent state |
| 06/27/1996 | WO1996019245A1 Retroviral vectors for expression in embryonic cells |
| 06/27/1996 | DE4445891A1 Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden Recombinant proteinase from Clostridium histolyticum and their use for the isolation of cells and cell aggregates |
| 06/27/1996 | CA2208324A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
| 06/27/1996 | CA2208210A1 Retroviral vectors for expression in embryonic cells |
| 06/26/1996 | EP0718400A2 Methods and compositions for controlling translation of HCV proteins |
| 06/26/1996 | EP0717750A1 Double-stranded peptide nucleic acids |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | CN1125479A Ligands for FLT3 receptors |
| 06/25/1996 | US5530114 Oligonucleotide modulation of arachidonic acid metabolism |
| 06/25/1996 | US5530096 Diagnosis and therapy of tumors, autoimmune diseases |
| 06/25/1996 | US5529774 In vivo transfer of the HSV-TK gene implanted retroviral producer cells |
| 06/20/1996 | WO1996018900A1 Prevention of protein aggregation |
| 06/20/1996 | WO1996018740A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | WO1996018737A2 Vectors and viruses for use in gene therapy |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | WO1996018390A1 Delivery of nucleic acid molecules to mucosal tissue |
| 06/20/1996 | WO1996018372A2 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/20/1996 | WO1996018303A1 Myoblast therapy for mammalian diseases |
| 06/20/1996 | CA2208224A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
| 06/20/1996 | CA2206669A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | CA2205968A1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/20/1996 | CA2183167A1 Myoblast therapy for mammalian diseases |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/19/1996 | EP0717110A1 LGMD gene |
| 06/19/1996 | EP0716711A1 Vector for gene therapy of the liver |
| 06/19/1996 | EP0716710A1 Methods of suppressing immune response by gene therapy |
| 06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | EP0716692A1 Methods of suppressing autoimmune response |
| 06/19/1996 | EP0716691A1 Methods of suppressing graft rejection |
| 06/19/1996 | EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |
| 06/19/1996 | EP0716604A1 Thiol-derivatized nucleosides and oligonucleosides |
| 06/19/1996 | EP0716591A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS |
| 06/19/1996 | EP0716570A1 Genetically modified human hematopoietic stem cells and their progeny |
| 06/19/1996 | CN1124980A Modified oligonucleotides having improved anti-influenza activity |
| 06/18/1996 | US5527928 Cationic transport reagents |
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/18/1996 | US5527700 Target antigens of transmission blocking antibodies for malaria parasites |
| 06/13/1996 | WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms |
| 06/13/1996 | WO1996017948A1 Methods, compositions and apparatus for cell transfection |
| 06/13/1996 | WO1996017947A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 06/13/1996 | WO1996017931A1 Human vascular ibp-like growth factor |
| 06/13/1996 | WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 06/13/1996 | WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | WO1996017823A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 06/13/1996 | WO1996017627A2 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 06/13/1996 | WO1995034670A3 Recombinant aav genome encoding immunodeficiency virus protein |
| 06/13/1996 | CA2208184A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 06/13/1996 | CA2207927A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 06/13/1996 | CA2207216A1 System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
| 06/13/1996 | CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | CA2206640A1 Human vascular ibp-like growth factor |
| 06/13/1996 | CA2206600A1 Methods, compositions and apparatus for cell transfection |
| 06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
| 06/12/1996 | EP0715632A1 Anti-sense oligonucleotides for aromatase inhibition |
| 06/12/1996 | EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 06/12/1996 | EP0690732A4 Gas driven gene delivery instrument |
| 06/12/1996 | EP0498843B1 Oligonucleotide analogs with novel linkages |
| 06/12/1996 | CN1124491A Inhibitor of stem cell proliferation and uses thereof |
| 06/12/1996 | CN1124460A Gas driven gene delivery instrument |
| 06/11/1996 | US5525467 Detection, diagnosis, therapy of alzheimer's disease |
| 06/07/1996 | WO1996017869A2 Interleukin-6 (il-6) antagonists |
| 06/07/1996 | CA2177837A1 Interleukin-6 (il-6) antagonists |
| 06/06/1996 | WO1996017072A2 Recombinant alphavirus vectors |
| 06/06/1996 | WO1996017071A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 06/06/1996 | WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination |
| 06/06/1996 | WO1996017063A1 Plasmids suitable for il-2 expression |
| 06/06/1996 | WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | WO1996017057A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 06/06/1996 | WO1996017053A1 Vectors for tissue-specific replication |
| 06/06/1996 | WO1996016989A1 p53 PROTEINS WITH ALTERED TETRAMERIZATION DOMAINS |
| 06/06/1996 | WO1996016975A1 Diagnosis of and therapy for hereditary haemorrhagic telangiectasia |
| 06/06/1996 | WO1996016676A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | WO1996016665A1 Cd40 associated proteins |
| 06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/06/1996 | WO1995032298A3 Safe vectors for gene therapy |
| 06/06/1996 | CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | CA2206574A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 06/06/1996 | CA2206441A1 Cd40 associated proteins |
| 06/06/1996 | CA2206305A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 06/06/1996 | CA2206205A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 06/06/1996 | CA2205964A1 Diagnosis of and therapy for hereditary haemorrhagic telangiectasia |
| 06/05/1996 | EP0714449A1 Oligonucleotide modulation of protein kinase c |
| 06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 06/05/1996 | EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus |
| 06/05/1996 | EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |